Guidelines for Corticosteroid use in Treatment of DMD
The guideline development subcommittee of the American Academy of Neurology has provided an update to the 2005 treatment guidelines for use of corticosteroids (CS) in Duchenne muscular dystrophy (DMD).
Saved in:
Main Author: | Vamshi K. Rao (Author) |
---|---|
Format: | Book |
Published: |
Pediatric Neurology Briefs Publishers,
2016-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perspectives on Everyday Life Challenges of Danish Young People With Duchenne Muscular Dystrophy (DMD) on Corticosteroids
by: Charlotte Handberg, et al.
Published: (2022) -
Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy
by: Melanie Gartz, et al.
Published: (2020) -
Draw attention to the teratogenic effect of DMD in MS treatment
by: Shi-Fang Hou, et al.
Published: (2020) -
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype
by: Brioschi Simona, et al.
Published: (2012) -
A female patient carrying a novel DMD mutation with non-random X-chromosome inactivation from a DMD family
by: Ming-Xia Sun, et al.
Published: (2024)